Pregnancy SmartShop formulas

Is it safe? · Pregnancy Smart

Monochorionic Diamniotic Twins: What MCDA Means

Assigned clinical reviewerMichael Yuzefovich· MD, FACOGDraft · pending clinical reviewUpdated

What does the evidence say about monochorionic diamniotic twins?

  1. The shared placenta is the defining clinical feature of MCDA twins. Blood-vessel connections can create complications that do not occur in the same way with separate placentas. Separate amniotic sacs do not remove the risks associated with sharing placental circulation. 1
  2. SMFM recommends establishing chorionicity and amnionicity in the first trimester. For MCDA pregnancies, surveillance for twin-twin transfusion syndrome begins at 16 weeks and continues at least every two weeks; concerns may justify more frequent visits. 2
  3. A surveillance scan can include growth, fluid in each sac, and Doppler assessments. These measurements are complementary. Appropriate fetal labeling is important so that a change in one twin's measurements is compared with the correct previous record. 3
  4. Twin anemia-polycythemia sequence can develop with little or no maternal symptom and without the fluid imbalance typical of twin-twin transfusion syndrome. Ask whether the surveillance plan includes the relevant middle cerebral artery Doppler measurements. 4
  5. Delivery planning remains individualized. Sharing a placenta does not by itself answer every question about vaginal versus cesarean birth. The babies' positions and health, maternal circumstances, and the experience of the birth team also matter. 5

When are MCDA twin monitoring decisions made?

  • First trimester. Early ultrasound should document the shared placenta and separate sacs.
  • Second trimester. From 16 weeks, follow the agreed specialist surveillance schedule.
  • Third trimester. As birth approaches, review current findings and the neonatal support that may be needed.

Questions to discuss with your care team

Decision pointWhat to clarify
Surveillance scheduleWho is coordinating the scans and what happens if an appointment is missed?
Scan componentsHow are fluid, growth, bladder findings, and Doppler being assessed?
Escalation planWhich findings require a fetal-care-center consultation?

Frequently asked questions

Do mo-di twins share the same sac?

No. MCDA twins share a placenta but have separate amniotic sacs. Monoamniotic twins share both, which creates a different set of monitoring and delivery considerations.

When should TTTS screening begin?

SMFM recommends starting at 16 weeks for MCDA twins and repeating at least every two weeks. A new concern can require assessment sooner, so ask which symptoms or ultrasound findings would change that schedule.

Is a growth scan the same as a complete shared-placenta check?

Not necessarily. Growth, amniotic fluid, bladder appearance, and Doppler measurements answer different questions. Ask what the visit includes and how the team is checking for the complications relevant to your twins.

Can there be a blood-count problem when fluid looks normal?

Yes. TAPS may occur without a major amniotic-fluid imbalance. Brain-artery Doppler findings help the specialist assess this possibility, which is why a normal-looking fluid measurement is not the whole surveillance assessment.

Does every MCDA pregnancy develop TTTS?

No. Sharing a placenta creates the risk, but it does not mean TTTS is inevitable. Scheduled surveillance is intended to identify concerning changes and allow timely specialist review if needed.

Will I automatically need a cesarean?

The delivery recommendation depends on more than the MCDA label. Discuss fetal positions, growth, any complications, maternal health, and local expertise. A new finding later in pregnancy can change the original plan.

Why does my report track Twin A and Twin B separately?

Consistent labels help the team compare each twin's growth, fluid, and blood-flow findings over time. Keep reports available when transferring care so the receiving team can understand how the babies were identified.

Can I use how I feel to rule out shared-placenta complications?

No. Some complications produce few maternal symptoms. Feeling well is welcome, but it does not replace the planned scans. Contact your care team about new symptoms or difficulty attending a surveillance visit.

Related in the library

References

  1. Surveillance of Monochorionic Twins

    ISUOG · https://www.isuog.org/clinical-resources/patient-information-series/patient-information-pregnancy-conditions/multiple-pregnancies/surveillance-of-monochorionic-twins.html

  2. Society for Maternal-Fetal Medicine Consult Series #72: Twin-twin transfusion syndrome and twin anemia-polycythemia sequence

    SMFM · https://publications.smfm.org/publications/574-society-for-maternal-fetal-medicine-consult-series-72/

  3. ISUOG Practice Guidelines (updated): role of ultrasound in twin pregnancy

    PubMed Central · https://pmc.ncbi.nlm.nih.gov/articles/PMC11788470/

  4. Twin-Anemia Polycythemia Sequence

    ISUOG · https://www.isuog.org/clinical-resources/patient-information-series/patient-information-pregnancy-conditions/multiple-pregnancies/twin-anemia-polycythemia-sequence.html

  5. Multiple Pregnancy

    ACOG · https://www.acog.org/womens-health/faqs/multiple-pregnancy

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.